137 related articles for article (PubMed ID: 15847992)
1. In vitro and in vivo studies of cyclosporin A-loaded microspheres based on copolymers of lactide and epsilon-caprolactone: comparison with conventional PLGA microspheres.
Li Y; Zhu KJ; Zhang JX; Jiang HL; Liu JH; Hao YL; Yasuda H; Ichimaru A; Yamamoto K
Int J Pharm; 2005 May; 295(1-2):67-76. PubMed ID: 15847992
[TBL] [Abstract][Full Text] [Related]
2. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
6. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
7. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
8. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
10. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
11. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
12. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
13. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle.
Lee ES; Park KH; Park IS; Na K
Int J Pharm; 2007 Jun; 338(1-2):310-6. PubMed ID: 17363202
[TBL] [Abstract][Full Text] [Related]
14. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.
Dong CM; Guo YZ; Qiu KY; Gu ZW; Feng XD
J Control Release; 2005 Sep; 107(1):53-64. PubMed ID: 16005093
[TBL] [Abstract][Full Text] [Related]
15. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
[TBL] [Abstract][Full Text] [Related]
17. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres.
Martinez B; Lairion F; Pena MB; Di Rocco P; Nacucchio MC
J Microencapsul; 1997; 14(2):155-61. PubMed ID: 9132467
[TBL] [Abstract][Full Text] [Related]
18. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
[TBL] [Abstract][Full Text] [Related]
19. Double walled POE/PLGA microspheres: encapsulation of water-soluble and water-insoluble proteins and their release properties.
Shi M; Yang YY; Chaw CS; Goh SH; Moochhala SM; Ng S; Heller J
J Control Release; 2003 Apr; 89(2):167-77. PubMed ID: 12711441
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
Prior S; Gander B; Irache JM; Gamazo C
J Antimicrob Chemother; 2005 Jun; 55(6):1032-6. PubMed ID: 15883176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
